Replies to post #199557 on Biotech Values

[DewDiligence]

ARLZ +5% on FDA approval of Yosprala (an FDC of aspirin + Prilosec):

http://finance.yahoo.com/news/aralez-announces-fda-approval-yosprala-133200544.html

ARLZ is the result of a reverse merger announced in mid 2015 (#msg-114404029).